Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

730
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
730
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

1.3K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.3K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

343
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
343
Aging01:26

Aging

1.1K
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multilayer brain connectivity and long-term cognitive changes in individuals at risk for Alzheimer's disease.

Journal of Alzheimer's disease : JAD·2026
Same author

Attention Networks Connectivity After Cognitive Rehabilitation in Alzheimer's Disease.

Journal of geriatric psychiatry and neurology·2026
Same author

Association of micronutrient levels with dementia risk in adults in Telangana, India: a cross-sectional study (2023-2024).

The Lancet regional health. Southeast Asia·2026
Same author

Social engagement, pleasure, and memory in musical reminiscence workshops for individuals with Alzheimer's disease.

Frontiers in human neuroscience·2026
Same author

Intensive care admissions in older adults: are we moving from ageism to ableism?

European geriatric medicine·2026
Same author

[Social isolation and loneliness among seniors: the place and role of psychologists].

Revue de l'infirmiere·2026
Same journal

"There'll always be something that I can do": A Qualitative Exploration of Nurse Practitioner-Led Community Dementia Care Enabling a Life of Dignity.

Dementia (London, England)·2026
Same journal

Choir Singing for People With Dementia and Their Care Partners: Exploring the Role of Bonding Social Capital.

Dementia (London, England)·2026
Same journal

Assistant Nurses' Experiences of Life Story Documentation: Insights Into the Construction and Application in Dementia Care Practice.

Dementia (London, England)·2026
Same journal

Hearing Loss and Dementia Prevalence Across Countries: Global Ecological Evidence in Females and Males.

Dementia (London, England)·2026
Same journal

Hounslow Health Inequalities in Dementia Care (HHIinD): Experiences of South Asian Ethnic Minority People Living With Dementia and Their Carers, and the Role of Arts, Heritage and Cultural Interventions.

Dementia (London, England)·2026
Same journal

From Diagnosis to Daily Care: Impact of Early Informational Support on the Burden of Family Caregiving.

Dementia (London, England)·2026
See all related articles

Related Experiment Video

Updated: Apr 16, 2026

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

14.8K

Dementia beyond 2025: Knowledge and uncertainties.

Paul-Ariel Kenigsberg1, Jean-Pierre Aquino2, Alain Bérard2

  • 1Fondation Médéric Alzheimer, Paris, France kenigsberg@med-alz.org.

Dementia (London, England)
|March 6, 2015
PubMed
Summary
This summary is machine-generated.

Preventing dementia and Alzheimer's disease by managing vascular and lifestyle factors is more realistic than treatment. Enhancing care through psychosocial research, assistive technologies, and dementia-friendly environments improves quality of life.

Keywords:
care environmentdementiapreventionprospectivepsychosocial interventions

More Related Videos

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.5K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K

Related Experiment Videos

Last Updated: Apr 16, 2026

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

14.8K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.5K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K

Area of Science:

  • Gerontology and Public Health
  • Neuroscience and Cognitive Science
  • Health Services Research

Background:

  • Drug development for dementia and Alzheimer's disease may not yield significant advances before 2025.
  • Prevention through vascular and lifestyle risk factor management is a more attainable goal than treatment.
  • Dementia care requires attention to education, cognitive reserve, and the cultural, social, and economic aspects of caregiving.

Purpose of the Study:

  • To explore realistic goals for dementia care, focusing on prevention and enhanced quality of life.
  • To identify key areas for public policy and research in dementia care.
  • To propose a systems approach for improving dementia care environments.

Main Methods:

  • Review of current challenges and emerging solutions in dementia care, including assistive technologies and serious games.
  • Analysis of public policy directions and research priorities.
  • Conceptualization of a systems approach integrating organizational, architectural, and psychosocial interventions.

Main Results:

  • Management of vascular and lifestyle risk factors offers a realistic prevention strategy.
  • Serious games and e-learning show potential for public and professional education.
  • A systems approach to dementia care environments can reduce symptoms and enhance quality of life.

Conclusions:

  • Prioritizing prevention and improving care quality through psychosocial research and supportive environments is crucial.
  • Dementia should be recognized as a distinct condition, separate from frailty or loss of autonomy.
  • Coordinated research networks and a focus on psychosocial research as an investment are needed to advance dementia care.